1. Home
  2. NDAQ vs EW Comparison

NDAQ vs EW Comparison

Compare NDAQ & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nasdaq Inc.

NDAQ

Nasdaq Inc.

HOLD

Current Price

$98.98

Market Cap

54.9B

Sector

Finance

ML Signal

HOLD

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$89.99

Market Cap

48.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NDAQ
EW
Founded
1971
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.9B
48.9B
IPO Year
2001
1999

Fundamental Metrics

Financial Performance
Metric
NDAQ
EW
Price
$98.98
$89.99
Analyst Decision
Strong Buy
Buy
Analyst Count
13
21
Target Price
$105.62
$96.37
AVG Volume (30 Days)
2.7M
3.5M
Earning Date
04-23-2026
04-23-2026
Dividend Yield
1.36%
N/A
EPS Growth
60.10
N/A
EPS
1.80
1.07
Revenue
$4,277,000,000.00
$6,067,600,000.00
Revenue This Year
$10.52
$13.39
Revenue Next Year
$8.17
$9.81
P/E Ratio
$54.95
$84.58
Revenue Growth
7.87
11.55
52 Week Low
$76.55
$72.30
52 Week High
$101.79
$96.29

Technical Indicators

Market Signals
Indicator
NDAQ
EW
Relative Strength Index (RSI) 64.57 53.15
Support Level $96.47 $81.19
Resistance Level $101.50 $93.91
Average True Range (ATR) 1.75 1.75
MACD -0.01 -0.12
Stochastic Oscillator 81.07 42.16

Price Performance

Historical Comparison
NDAQ
EW

About NDAQ Nasdaq Inc.

Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its trading business (about 22.5% of sales), the company sells market and financial data to investors, offers Nasdaq-branded indexes, and lists companies through its capital access segment (42.5%). Nasdaq's newest segment, financial technology, was primarily constructed through the acquisitions of Verafin and Adenza and has expanded the company into capital management, financial crime, and regulatory compliance software (35%) as it seeks to become a diversified technology company.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: